NO933714D0 - Oftalmiske preparater omfattende kombinasjoner av en karbonsyreanhydraseinhibitor og en beta-adrenerg antagonist - Google Patents

Oftalmiske preparater omfattende kombinasjoner av en karbonsyreanhydraseinhibitor og en beta-adrenerg antagonist

Info

Publication number
NO933714D0
NO933714D0 NO1993933714A NO933714A NO933714D0 NO 933714 D0 NO933714 D0 NO 933714D0 NO 1993933714 A NO1993933714 A NO 1993933714A NO 933714 A NO933714 A NO 933714A NO 933714 D0 NO933714 D0 NO 933714D0
Authority
NO
Norway
Prior art keywords
beta
combinations
carboxylic acid
anhydrase inhibitor
adrenergic antagonist
Prior art date
Application number
NO1993933714A
Other languages
English (en)
Other versions
NO306196B1 (no
NO933714L (no
Inventor
John J Baldwin
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27103852&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO933714(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO933714D0 publication Critical patent/NO933714D0/no
Publication of NO933714L publication Critical patent/NO933714L/no
Publication of NO306196B1 publication Critical patent/NO306196B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO933714A 1991-04-17 1993-10-15 Oftalmiske preparater omfattende kombinasjoner av en karbonsyreanhydraseinhibitor og en <beta>-adrenerg antagonist og anvendelse av disse NO306196B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68671891A 1991-04-17 1991-04-17
US83491392A 1992-02-13 1992-02-13
PCT/US1992/002903 WO1992018124A1 (en) 1991-04-17 1992-04-09 OPHTHALMIC COMPOSITIONS COMPRISING COMBINATIONS OF A CARBONIC ANHYDRASE INHIBITOR AND A β-ADRENERGIC ANTAGONIST

Publications (3)

Publication Number Publication Date
NO933714D0 true NO933714D0 (no) 1993-10-15
NO933714L NO933714L (no) 1993-10-15
NO306196B1 NO306196B1 (no) 1999-10-04

Family

ID=27103852

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933714A NO306196B1 (no) 1991-04-17 1993-10-15 Oftalmiske preparater omfattende kombinasjoner av en karbonsyreanhydraseinhibitor og en <beta>-adrenerg antagonist og anvendelse av disse

Country Status (25)

Country Link
EP (1) EP0509752B1 (no)
JP (1) JP2527513B2 (no)
KR (1) KR920019348A (no)
CN (1) CN1073421C (no)
AT (1) ATE182787T1 (no)
AU (1) AU648659C (no)
CA (1) CA2065965C (no)
CH (1) CH0509752H1 (no)
CY (1) CY2146B1 (no)
CZ (1) CZ285129B6 (no)
DE (3) DE69229688T4 (no)
DK (1) DK0509752T3 (no)
ES (1) ES2133304T3 (no)
GR (1) GR3031467T3 (no)
HK (1) HK1009251A1 (no)
IE (1) IE921240A1 (no)
IL (1) IL101537A (no)
LU (1) LU90506I2 (no)
MX (1) MX9201785A (no)
NL (1) NL990041I2 (no)
NO (1) NO306196B1 (no)
RO (1) RO113612B1 (no)
SK (1) SK282039B6 (no)
WO (1) WO1992018124A1 (no)
YU (1) YU39392A (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2129037C (en) * 1992-02-21 1998-03-24 Thomas Robert Dean Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers
US5932572A (en) * 1992-02-21 1999-08-03 Alcon Laboratories, Inc. Topical anti-glaucoma compositions
US6071904A (en) * 1996-12-11 2000-06-06 Alcon Laboratories, Inc. Process for manufacturing ophthalmic suspensions
FI981473A (fi) * 1998-06-25 1999-12-26 Orion Yhtymae Oyj Menetelmä pulmonaalihypertension hoitamiseksi
TWI298257B (en) 2001-05-31 2008-07-01 Allergan Inc Hypotensive lipid and timolol compositions and methods of using same
CN100345594C (zh) * 2004-01-19 2007-10-31 无锡杰西医药科技有限公司 乙酰唑胺滴眼液
US8211450B2 (en) * 2010-05-05 2012-07-03 Senju Usa, Inc. Ophthalmic composition
US9061034B2 (en) 2010-07-29 2015-06-23 Allergan, Inc. Preservative free bimatoprost and timolol solutions
HRP20220626T1 (hr) 2010-07-29 2022-06-24 Allergan, Inc. Otopine bimatoprosta i timolola bez konzervansa
JP5893204B1 (ja) * 2015-02-23 2016-03-23 参天製薬株式会社 防腐効果のある医薬の組合せ
TW201726127A (zh) * 2016-01-29 2017-08-01 參天製藥股份有限公司 含有多佐胺、高分子及硼酸之醫藥組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863922A (en) * 1984-12-12 1989-09-05 Merck & Co., Inc. Substituted aromatic sulfonamides as antiglaucoma agents, compositions and use

Also Published As

Publication number Publication date
KR920019348A (ko) 1992-11-19
AU648659C (en) 2008-02-14
HK1009251A1 (en) 1999-05-28
EP0509752A3 (en) 1993-03-03
EP0509752B1 (en) 1999-08-04
CH0509752H1 (no) 2012-11-30
DE69229688T2 (de) 2000-02-24
DE69229688D1 (de) 1999-09-09
CA2065965C (en) 1998-06-16
ES2133304T3 (es) 1999-09-16
SK110393A3 (en) 1994-02-02
AU648659B2 (en) 1994-04-28
DE69229688C5 (de) 2010-10-21
IL101537A0 (en) 1992-12-30
SK282039B6 (sk) 2001-10-08
IL101537A (en) 1997-11-20
CY2146B1 (en) 2002-06-21
MX9201785A (es) 1992-10-01
CZ285129B6 (cs) 1999-05-12
JP2527513B2 (ja) 1996-08-28
EP0509752A2 (en) 1992-10-21
LU90506I2 (fr) 2000-03-28
ATE182787T1 (de) 1999-08-15
NO306196B1 (no) 1999-10-04
IE921240A1 (en) 1992-10-21
CZ209893A3 (en) 1994-06-15
RO113612B1 (ro) 1998-09-30
DK0509752T3 (da) 1999-12-06
DE69229688T4 (de) 2010-08-19
DE10075002I1 (de) 2000-03-30
CN1066781A (zh) 1992-12-09
NO933714L (no) 1993-10-15
JPH05117167A (ja) 1993-05-14
CN1073421C (zh) 2001-10-24
YU39392A (sh) 1995-12-04
CA2065965A1 (en) 1992-10-18
NL990041I1 (nl) 2000-02-01
GR3031467T3 (en) 2000-01-31
NL990041I2 (nl) 2000-04-03
DE10075002I2 (de) 2004-07-01
WO1992018124A1 (en) 1992-10-29
AU1497992A (en) 1992-10-22

Similar Documents

Publication Publication Date Title
IT1233108B (it) Dispositivo per la correzione delle anomalie di rifrazione dell&#39;occhio.
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
DE68919146D1 (de) Ausgewählte Stämme von Lactobacillus enthaltende pharmazeutische Zusammensetzungen.
NO933714L (no) Oftalmiske preparater omfattende kombinasjoner av en karbonsyreanhydraseinhibitor og en beta-adrenerg antagonist
ATE199250T1 (de) Sulfonamidocarbonylpyridin-2-carbonsäureamide und ihre verwendung als arzneimittel
NO923798D0 (no) Fremgangsmaate for fremstilling og anvendelse av nye acylaler av imidazol-5-karboksylsyrederivater
IT1238825B (it) Dispositivo per la correzione chirurgica dell&#39;ametropia.
DK0679717T3 (da) Opløselig interferon-receptor og fremstilling og anvendelse heraf
ATE195872T1 (de) Aufbewahren von stammzellen
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
DK1040191T3 (da) RANTES-mutanter og terapeutiske anvendelser heraf
DE69100171D1 (de) Synergistische kombination zur ophthalmischen verwendung.
ITRM940160A0 (it) Procedimento e dispositivo per la riduzione dell&#39;inserimento di ossigeno in un monocristallo di silicio.
IT1225800B (it) Polarizzatore doppio, per l&#39;osservazione dei cinescopi in genere
IT8919216A0 (it) Dispositivo per la cura chirurgica dell&#39;astigmatismo.
ATE302611T1 (de) Humanes wachstumshormon als hilfe gegen unterkühlung
DE69028466D1 (de) Optisch aktive, Fluor enthaltende Alkohole und Flüssigkristallabkömmlinge davon
FI971012A0 (fi) 1,4-dihydro-4-okso-3-kinoliinikarboksyylihappojohdannaiset ja niiden käyttö
ITMI910913U1 (it) Portaombrelli portatile, in particolare per l&#39;utilizzo all&#39;interno di autovetture
NO914779D0 (no) Adenosin-forbindelse i ny krystallform, fremgangsmaate fordens fremstilling og terapeutisk anvendelse derav

Legal Events

Date Code Title Description
MK1K Patent expired